Heart Test Laboratories
HSCS
10 hedge funds and large institutions have $545K invested in Heart Test Laboratories in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 10 → 10 (0)
0% less ownership
Funds ownership: 0.06% → 0.06% (-0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
6% less capital invested
Capital invested by funds: $579K → $545K (-$33.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TWM
Tradition Wealth Management
Edina,
Minnesota
|
+$60.3K |
| 2 |
ASW
Astoria Strategic Wealth
Conroe,
Texas
|
+$23.2K |
| 3 |
Renaissance Technologies
New York
|
+$12.4K |
| 4 |
HF
HRT Financial
New York
|
+$11.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$5.96K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OLVIG
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
|
-$42.7K |
| 2 |
AWM
AE Wealth Management
Topeka,
Kansas
|
-$37.9K |
| 3 |
Two Sigma Investments
New York
|
-$15.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.56K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.09K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TWM
1
Tradition Wealth Management
Edina,
Minnesota
| $135K | +$60.3K | +617 | +71% |
|
|
OLVIG
2
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
| $102K | -$42.7K | -437 | -28% |
|
|
AWM
3
AE Wealth Management
Topeka,
Kansas
| $100K | -$37.9K | -388 | -26% |
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $78K | – | – | – |
|
|
CD
5
Chapin Davis
Baltimore,
Maryland
| $49.8K | – | – | – |
|
|
6
Renaissance Technologies
New York
| $32K | +$12.4K | +127 | +56% |
|
|
ASW
7
Astoria Strategic Wealth
Conroe,
Texas
| $21.4K | +$23.2K | +237 | New |
|
|
TSS
8
Two Sigma Securities
New York
| $15.8K | +$5.96K | +61 | +54% |
|
|
HF
9
HRT Financial
New York
| $10K | +$11.7K | +120 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $812 | -$1.56K | -16 | -64% |
|
11
Wells Fargo
San Francisco,
California
| $20 | – | – | – |
|
|
12
Two Sigma Investments
New York
| – | -$15.1K | -153 | Closed |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$1.09K | -11 | Closed |
|
HSCS Hedge Fund Activity: Q2 2023 in Review
10 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q2 2023, worth a combined $545K — down 5.8% from $579K a quarter earlier.
Fund positioning in HSCS was balanced in Q2 2023: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was Tradition Wealth Management, adding an estimated $60.3K. The largest seller was Oliver Lagore Vanvalin Investment Group, cutting an estimated $42.7K.
- 10 institutional investors held Heart Test Laboratories (HSCS) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $545K of Heart Test Laboratories stock for Q2 2023, down 5.8% quarter-over-quarter.
- 2 funds opened new Heart Test Laboratories positions in Q2 2023 and 2 closed out, a net change of 0 holders.
- The largest Heart Test Laboratories buyer in Q2 2023 was Tradition Wealth Management, an estimated $60.3K added.
- The largest Heart Test Laboratories seller in Q2 2023 was Oliver Lagore Vanvalin Investment Group, an estimated $42.7K sold.
Based on aggregated 13F filings for Q2 2023.